Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: GOG 0186J Principal Investigator: Mutch, David
Title: A Randomized Phase IIB Evaluation of Weekly Paclitaxel (NSC #673089) Plus Pazopanib (NSC #737754 (IND #75648) Versus Weekly Paclitaxel Plus Placebo In The Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma (NCI Ver 1/19/12)
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
You are being asked to take part in this study because you have ovarian, fallopian tube, or primary peritoneal cancer that has failed to respond to initial chemotherapies given to you or has re-grown after surgery, radiation therapy, or other forms of therapy.
The purpose of this study is to find out if the drugs elesclomol sodium and paclitaxel will work in treating your type of cancer and to find out what side effects are caused by treatment with this drug combination.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)